SCHEMBL29699277

SCHEMBL29699277

Cc1cccc(-c2ccccc2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.58
TSHR P16473 2/20 0.57
RAB9A P51151 2/20 0.57
NPC1 O15118 1/20 0.57
HPGD P15428 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
LMNA P02545 1/20 0.53
ALOX12 P18054 1/20 0.53
ENPP3 O14638 2/20 0.50
ALDH1A1 P00352 2/20 0.50
MAOA P21397 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
POLB P06746 1/20 0.48
MAPT P10636 1/20 0.48
CTDSP1 Q9GZU7 1/20 0.48
PTPN5 P54829 1/20 0.48
CNR1 P21554 2/20 0.47
CNR2 P34972 2/20 0.47
DHODH Q02127 1/20 0.47
PPARG P37231 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL27980187 1.00 ACHE (0.58) ACHETSHRRAB9ANPC1HPGD
SCHEMBL200730 1.00 ACHE (0.58) ACHETSHRRAB9ANPC1HPGD
SCHEMBL20689786 0.97 TSHR (0.55) ACHETSHRRAB9ANPC1HPGD
SCHEMBL28284301 0.97 TSHR (0.55) ACHETSHRRAB9ANPC1HPGD
SCHEMBL19503240 0.97 TSHR (0.55) ACHETSHRRAB9ANPC1HPGD
Hydrogen Sulfide SCHEMBL27914332 0.97 TSHR (0.55) ACHETSHRRAB9ANPC1HPGD
SCHEMBL28660662 0.97 TSHR (0.55) ACHETSHRRAB9ANPC1HPGD
Hydrochloric Acid SCHEMBL598365 0.95 TSHR (0.53) ACHETSHRRAB9ANPC1HPGD
SCHEMBL28043537 0.95 TSHR (0.53) ACHETSHRRAB9ANPC1HPGD
SCHEMBL18797759 0.94 ACHE (0.65) ACHETSHRRAB9ANPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078146-A1 EPHA2 TARGETING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2026-03-19 US claimed
CN-114790226-A Antibacterial peptide and preparation method thereof 正大天晴药业集团股份有限公司 2022-07-26 CN claimed
US-20260078146-A1 EPHA2 TARGETING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2026-03-19 US disclosed
EP-4689796-A1 COMPOSITION Merck Patent GmbH (DE) 2026-02-11 EP disclosed
WO-2025228800-A1 MATERIALS FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2025-11-06 WO disclosed
EP-4619383-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2025-09-24 EP disclosed
EP-4605408-A2 EPHA2 TARGETING AGENTS AND USES THEREOF The Regents of University of California (US) 2025-08-27 EP disclosed
WO-2025132194-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2025-06-26 WO disclosed
WO-2025087892-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2025-05-01 WO disclosed
US-20250135059-A1 COMPOSITIONS COMPRISING FRAGRANCE MATERIALS THE PROCTER & GAMBLE COMPANY 2025-05-01 US disclosed
US-20240336868-A1 COMPOSITIONS COMPRISING ADAMANTYL ESTER-CONTAINING COMPOUNDS THE PROCTER & GAMBLE COMPANY 2024-10-10 US disclosed
EP-4165052-A1 HETEROCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2023-04-19 EP disclosed
WO-2023041454-A1 BORONIC HETEROCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-03-23 WO disclosed
US-20230047816-A1 PFKFB3 INHIBITORS AND THEIR USES GERO PTE. LTD. (SG) 2023-02-16 US disclosed
EP-4126868-A1 MATERIALS FOR ELECTRONIC DEVICES Merck Patent GmbH (DE) 2023-02-08 EP disclosed
EP-4077315-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2022-10-26 EP disclosed
EP-4031549-A1 PERI-CONDENSED HETEROCYCLIC COMPOUNDS AS MATERIALS FOR ELECTRONIC DEVICES Merck Patent GmbH (DE) 2022-07-27 EP disclosed
CN-114790226-A Antibacterial peptide and preparation method thereof 正大天晴药业集团股份有限公司 2022-07-26 CN disclosed
CN-113652705-B Method for synthesizing fluorenone through catalytic electrolysis of N-hydroxyphthalimide 北京工业大学 2022-07-22 CN disclosed
WO-2022129113-A1 NITROGENOUS HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230047816-A1 PFKFB3 INHIBITORS AND THEIR USES PFKFB3, PFKFB4, PFKFB1 ACHE 3309/4885TSHR 4576/4885RAB9A 4602/4885
US-20260078146-A1 EPHA2 TARGETING AGENTS AND USES THEREOF EPHA2, EGFR, DNER ACHE 4156/4885TSHR 734/4885RAB9A 2698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.